These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7585066)

  • 1. Long-term delivery of a lysosomal enzyme by genetically modified fibroblasts in dogs.
    Moullier P; Bohl D; Cardoso J; Heard JM; Danos O
    Nat Med; 1995 Apr; 1(4):353-7. PubMed ID: 7585066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts.
    Moullier P; Bohl D; Heard JM; Danos O
    Nat Genet; 1993 Jun; 4(2):154-9. PubMed ID: 8348154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous systemic secretion of a lysosomal enzyme by genetically modified mouse skin fibroblasts.
    Moullier P; Maréchal V; Danos O; Heard JM
    Transplantation; 1993 Aug; 56(2):427-32. PubMed ID: 8356601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo delivery of human alpha-L-iduronidase in mice implanted with neo-organs.
    Salvetti A; Moullier P; Cornet V; Brooks D; Hopwood JJ; Danos O; Heard JM
    Hum Gene Ther; 1995 Sep; 6(9):1153-9. PubMed ID: 8527473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for lysosomal disorders.
    Naffakh N; Bohl D; Salvetti A; Moullier P; Danos O; Heard JM
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S11-6. PubMed ID: 8177709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice.
    Gao C; Sands MS; Haskins ME; Ponder KP
    Mol Ther; 2000 Sep; 2(3):233-44. PubMed ID: 10985954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer.
    Wolfe JH; Schuchman EH; Stramm LE; Concaugh EA; Haskins ME; Aguirre GD; Patterson DF; Desnick RJ; Gilboa E
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2877-81. PubMed ID: 2158095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated gene therapy for mucopolysaccharidosis VII: involvement of cross-correction in wide-spread distribution of the gene products and long-term effects of CTLA-4Ig coexpression.
    Kosuga M; Takahashi S; Sasaki K; Li XK; Fujino M; Hamada H; Suzuki S; Yamada M; Matsuo N; Okuyama T
    Mol Ther; 2000 May; 1(5 Pt 1):406-13. PubMed ID: 10933961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts.
    Naffakh N; Henri A; Villeval JL; Rouyer-Fessard P; Moullier P; Blumenfeld N; Danos O; Vainchenker W; Heard JM; Beuzard Y
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3194-8. PubMed ID: 7724539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.
    Sleeper MM; Fornasari B; Ellinwood NM; Weil MA; Melniczek J; O'Malley TM; Sammarco CD; Xu L; Ponder KP; Haskins ME
    Circulation; 2004 Aug; 110(7):815-20. PubMed ID: 15289379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs.
    Wang B; O'Malley TM; Xu L; Vite C; Wang P; O'Donnell PA; Ellinwood NM; Haskins ME; Ponder KP
    Mol Genet Metab; 2006 Jan; 87(1):8-21. PubMed ID: 16275036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-correction of beta-glucuronidase deficiency by retroviral vector-mediated gene transfer.
    Taylor RM; Wolfe JH
    Exp Cell Res; 1994 Oct; 214(2):606-13. PubMed ID: 7925654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral cDNA transfer to the RPE: stable expression and modification of metabolism.
    Ray J; Wolfe JH; Aguirre GD; Haskins ME
    Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1658-66. PubMed ID: 9699555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human beta-glucuronidase. I. Recognition and uptake by animal fibroblasts suggests animal models for enzyme replacement studies.
    Frankel HA; Glaser JH; Sly WS
    Pediatr Res; 1977 Jul; 11(7):811-6. PubMed ID: 876701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adsorptive endocytosis of lysosomal enzymes by human fibroblasts: presence of two different functional systems that deliver an acid hydrolase to lysosomes.
    González-Noriega A; Coutiño R; Saavedra VM; Barrera R
    Arch Biochem Biophys; 1989 Feb; 268(2):649-58. PubMed ID: 2913951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy on the Sly.
    Sly WS
    Nat Genet; 1993 Jun; 4(2):105-6. PubMed ID: 8348142
    [No Abstract]   [Full Text] [Related]  

  • 17. Transplantation of retrovirus-transduced canine keratinocytes expressing the beta-galactosidase gene.
    Stockschläder MA; Schuening FG; Graham TC; Storb R
    Gene Ther; 1994 Sep; 1(5):317-22. PubMed ID: 7584097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer.
    Wolfe JH; Sands MS; Barker JE; Gwynn B; Rowe LB; Vogler CA; Birkenmeier EH
    Nature; 1992 Dec 24-31; 360(6406):749-53. PubMed ID: 1465145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term secretion of therapeutic proteins from genetically modified skeletal muscles.
    Naffakh N; Pinset C; Montarras D; Li Z; Paulin D; Danos O; Heard JM
    Hum Gene Ther; 1996 Jan; 7(1):11-21. PubMed ID: 8825864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level human adenosine deaminase expression in dog skin fibroblasts is not sustained following transplantation.
    Ramesh N; Lau S; Palmer TD; Storb R; Osborne WR
    Hum Gene Ther; 1993 Feb; 4(1):3-7. PubMed ID: 8461381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.